Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Want to cut your energy bills? Here’s how five experts are doing it 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
SAN DIEGO, Feb. 24, 2017 -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 2:15 p.m. PT on Thursday, March 2, at Biocom's Global Life Science Partnering Conference (La Jolla – March 1-2). A copy of the presentation will be available through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.
About Vical
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.
Contact: Tony Ramos (858) 646-1127 Website: www.vical.com
